Printer Friendly

Browse T cells topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Naperville Park District to dedicate Chuck Papanos Honorary Garden July 30. Submitted by Naperville Park District Jul 25, 2021 216
Honoring a can-do man. Lauren Rohr lrohr@dailyherald.com Jul 24, 2021 549
Eight-weeks between first and second Pfizer vaccine doses the 'sweet spot' for fighting Delta variant; 'The decision to put it to eight weeks is really balancing all the wider issues, the pros and cons'. By, Lucy John Jul 23, 2021 754
Anocca announces USD47m from Series B Financing. Jul 22, 2021 186
Anocca announces USD47m from Series B Financing. Jul 22, 2021 187
Anocca announces USD47m from Series B Financing. Jul 22, 2021 188
Eureka Therapeutics Initiates Phase I/II ARYA-3 Clinical Trial of GPC3 Targeting ARTEMIS T Cell Therapy in Liver Cancer. Jul 22, 2021 422
TScan Therapeutics to present discovery of T cell targets for COVID-19. Jul 21, 2021 205
Merus announces publication on MCLA-145's mechanism of action. Jul 21, 2021 232
Single Institutional Experience on Orbital Inflammatory Pseudotumor: Diagnostic and Management Challenge. Derakhshandeh, Roshanak; Dimopoulos, Yiannis Petros; Goodglick, Todd Alan; Chanine, Joeffrey; Sabet, Clinical report Jul 21, 2021 3121
Laboratory Infectolab Americas Releases COVID-19 T-cell Test. Jul 20, 2021 367
I Came When Music Was More Of Passion Than Money - Late Sound Sultan. Jul 17, 2021 873
Adicet Bio announces formation of Scientifc Advisory Board. Jul 15, 2021 213
Rubius Therapeutics announces publication of RTX-240 preclinical data. Jul 15, 2021 204
ImmunityBio Authorized to Proceed with Phase 1/2/3 Randomized Trial in South Africa of Their Dual-Antigen T-Cell Vaccine as a Universal Boost in Previously Vaccinated Participants Against COVID-19. Jul 15, 2021 759
iBio reports successful preclinical studies with COVID vaccine candidate. Jul 15, 2021 261
Artax Biopharma receives UK authorisation for AX-158 Phase one clinical trial. Jul 14, 2021 155
Artax Biopharma receives UK authorisation for AX-158 Phase one clinical trial. Jul 14, 2021 156
ImmunityBio gets OK from South Africa for dual-antigen T-cell for Covid booster. Jul 14, 2021 300
First Patient Dosed in Phase 1 Clinical Trial Evaluating CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma. Jul 14, 2021 607
J&J says COVID shot shows neutralizing antibody activity against Delta variant. Jul 14, 2021 209
NBBF Dedicates D'Tigers Victories Over US, Argentina To Sound Sultan. Jul 13, 2021 256
Tevogen Bio wins FDA clearance of IND Application for TVGN-489 for COVID-19. Jul 13, 2021 232
Tevogen Bio wins FDA clearance of IND Application for TVGN-489 for COVID-19. Jul 13, 2021 231
Lava Therapeutics announces treatment of first patient in Phase 1/2a of LAVA-051. Jul 13, 2021 306
Genocea doses first patient in Phase 1/2a TiTAN clinical trial for GEN-011. Jul 13, 2021 166
'He Lived An Exemplary Life,' President Buhari Lauds Sound Sultan. Jul 12, 2021 228
Sound Sultan Buried Amidst Tears, Encomiums. Obituary Jul 12, 2021 332
Kymera Therapeutics presents new preclinical data on STAT3 degraders. Jul 12, 2021 233
Nigeria loses Sound Sultan, ace musician, actor and rapper, to cancer. Jul 11, 2021 490
Eurofins Viracor unveils the SARS-CoV-2 inSIGHT T Cell immunity testing tool. Jul 9, 2021 216
Eurofins Viracor unveils the SARS-CoV-2 inSIGHT T Cell immunity testing tool. Jul 9, 2021 215
Eurofins Viracor Launches Coronavirus SARS-CoV-2 inSIGHT T Cell Immunity Testing. Jul 9, 2021 349
4D pharma publishes research showing LBP MRx1299 improving the activity of CAR-T. Jul 6, 2021 185
Achilles Therapeutics enroll first patient in ongoing Phase I/IIa study in NSCLC. Jul 1, 2021 279
SenlangBio initiates first-in-human trial in recurrent brain cancer. Jul 1, 2021 268
Shiitake Mushrooms Boost Immunity. Jul 1, 2021 190
Athersys announces publication of research data on MAPC. Jun 30, 2021 260
Cullinan receives FDA clearance of IND application for CLN-619. Jun 29, 2021 180
Vaccibody to trial two new SARS CoV-2 virus DNA vaccine candidates. Jun 29, 2021 203
Vaccibody to trial two new SARS CoV-2 virus DNA vaccine candidates. Jun 29, 2021 202
Vaccibody to trial two new SARS CoV-2 virus DNA vaccine candidates. Jun 29, 2021 201
Precision BioSciences, SpringsWorks dose 1st patient in PBCAR269A trial. Jun 28, 2021 266
Sana's data shows survival of transplanted stem cells without immunosuppression. Jun 27, 2021 277
Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma for Relapsed and Refractory Multiple Myeloma. Jun 25, 2021 386
CellPoint signs contract with Lonza's Personalized Medicine Business Unit. Jun 24, 2021 159
CellPoint signs contract with Lonza's Personalized Medicine Business Unit. Jun 24, 2021 158
VBI Vaccines,Brii Bio present data on BRII-179 study for hepatitis B. Jun 23, 2021 266
Blackstone commits $250M toward new CAR-T company with Intellia Therapeutics. Jun 22, 2021 332
C4 Therapeutics presents preclinical data on CFT7455. Jun 21, 2021 392
Auris Medical announces puvlication of results from study with OligoPhore. Jun 21, 2021 341
NextCure announces publication of NC410 preclinical data. Jun 21, 2021 176
Harbour BioMed signs collaboration agreement with Dana-Farber Cancer Institute. Jun 16, 2021 166
Harbour BioMed signs collaboration agreement with Dana-Farber Cancer Institute. Jun 16, 2021 167
C4 Therapeutics first patient dosed in phase 1/2 clinical trial on CFT7455. Jun 14, 2021 238
Mustang Bio reports updated interim Phase 1/2 data for MB-106. Jun 11, 2021 268
Equillium presents data on CD6 on T Cells with Itolizumab. Jun 10, 2021 201
First Clinical Trial Application Authorization Received in the EU for its Phase 2 Study of NT-I7 and Opdivo. Jun 10, 2021 338
Olivia-Grace to start new treatment. JOANNE WELFORD joanne.welford@reachplc.com @joannewelford Jun 9, 2021 538
Adaptive Biotechnologies publishes data on COVID-19 vaccine, T-Cell response. Jun 9, 2021 202
LATEST COMPANY NEWS. Jun 8, 2021 14128
Mustang Bio to host KOL webinar on MB-106 CD20-targeted CAR T. Jun 7, 2021 198
Hookipa Pharma reports 'positive' Phase 1 data from study of HB-200. Jun 7, 2021 213
Kite says Tecartus shows high response rate in adults in Phase 1/2 study. Jun 4, 2021 398
Precision BioSciences provides update on PBCAR0191 study, PBCAR19B data. Jun 4, 2021 372
Harpoon Therapeutics presents updated data for phase 1/2a trial for HPN424. Jun 4, 2021 411
Achilles Therapeutics presents phase I/IIa clinical trial design of CHIRON. Jun 4, 2021 190
G1 Therapeutics presents data on phase 2 trial on COSELA. Jun 4, 2021 295
Selecta announcer paper on hepatic tolerogenic potential of ImmTOR. Jun 1, 2021 193
Software package enables deeper understanding of cancer immune responses. Jun 1, 2021 184
A Primer on Chimeric Antigen Receptor T-cell Therapy: What Does It Mean for Pathologists? Cushman-Vokoun, Allison M.; Voelkerding, Karl V.; Fung, Mark K.; Nowak, Jan A.; Thorson, John A.; Du Report Jun 1, 2021 10823
The occurrence of varicella after zoster vaccination in a patient with rheumatoid arthritis receiving tofacitinib. Kao, Chung-Mao; Hsieh, Tsu-Yi; Lai, Kuo-Lung Letter to the editor Jun 1, 2021 912
Blood cancer patients can fight Covid with T cells: Study. May 29, 2021 345
Imugene believes it has found "the holy grail of cancer therapy". May 29, 2021 698
Imugene believes it has found "the holy grail of cancer therapy". May 29, 2021 698
Blood cancer patients can fight Covid with T cells: Study. May 29, 2021 345
Chimeric Therapeutics initiates second dose cohort in chlorotoxin CAR T cell phase 1 trial. May 25, 2021 330
Chimeric Therapeutics initiates second dose cohort in chlorotoxin CAR T cell phase 1 trial. May 25, 2021 330
Janssen Posts Updated Phase 1 Results for Teclistamab Suggesting Deep, Durable Responses in Patients with Heavily Pretreated Multiple Myeloma. May 25, 2021 639
ImmunityBio expands COVID-19 vaccine candidate trials. May 25, 2021 307
Imugene licenses CD19 Oncolytic virus from City of Hope to turn CAR T therapy against solid tumours. May 19, 2021 655
Imugene licenses CD19 Oncolytic virus from City of Hope to turn CAR T therapy against solid tumours. May 19, 2021 655
Mustang Bio, City of Hope dose first patient in Phase 1 trial of MB-101. May 18, 2021 180
Oxford Immunotec's T-SPOT.COVID Test used in COVID-19 Human Challenge Study. May 18, 2021 328
Soligenix reports Q1 EPS (6c), consensus (45c). Financial report May 17, 2021 234
Gracell reports Q1 EPS (5c), consensus (21c). Financial report May 17, 2021 366
Rubius Therapeutics announces publication of RTX-321 preclinical data. May 12, 2021 182
Tevogen Bio's TVGN-489 Allogeneic SARS-CoV-2 Specific Cytotoxic T Cell Therapy Demonstrates Strong Anti-Viral Activity in Preclinical Study. May 11, 2021 557
Soligenix's HyBryte awarded Innovation Passport in the U.K. May 10, 2021 160
BioVaxys increases patent portfolio and submits commercial trademark application for CoviDTH test. May 3, 2021 176
BioVaxys increases patent portfolio and submits commercial trademark application for CoviDTH test. May 3, 2021 175
Cabaletta Bio announces pipeline highlights. May 3, 2021 170
Developmental Origins of Delayed Adult Immune Response: The AhR Connection. Pascual, Florencia May 1, 2021 1008
Recent Advances in Digestive Tract Tumors: Updates From the 5th Edition of the World Health Organization "Blue Book". Gonzalez, Raul S.; Raza, Anwar; Propst, Robert; Adeyi, Oyedele; Bateman, Justin; Sopha, Sabrina C.; Report May 1, 2021 14111
Episomal reprogramming of Duchenne muscular dystrophy patients derived CD3+ T cells towards induced pluripotent stem cells. Mehwish Zehravi, Mohsin Wahid and Junaid Ashraf Apr 30, 2021 2936
Xencor Doses First Subject in Phase 1 Study of XmAb564, an Engineered IL-2 Cytokine in Development for Autoimmune Diseases. Apr 29, 2021 336
PerkinElmer's Oxford Immunotec announce T-SPOT COVID-19 kit used in DIRECT study. Apr 29, 2021 189
Oxford Immunotec's T-SPOT Discovery SARS-CoV-2 test used in UK Com-COV trial. Apr 27, 2021 415
Marker Therapeutics to present mTAA-specific T cell manufacturing data. Apr 27, 2021 167
Vaxart to host KOL webinar on T-Cell responses for COVID-19 vaccines. Apr 26, 2021 189
Chimeric Therapeutics progresses to second dosing level with first patient cohort in CLTX CAR T Phase 1 trial. Apr 23, 2021 282
Chimeric Therapeutics progresses to second dosing level with first patient cohort in CLTX CAR T Phase 1 trial. Apr 23, 2021 282
US FDA Accepts Shorla Pharma Application for its SH-111 Oncology Drug Designed to Treat T-Cell Leukemia. Apr 23, 2021 296
Codiak announces publication of data on exoSTING preclinical development. Apr 22, 2021 272
Janux Therapeutics Raises USD 125m in Series B Financing. Apr 21, 2021 385
Evaxion Biotech presents paper on deep data on immune complex stability. Apr 20, 2021 325
Allogene Therapeutics receives IND clearance for ALLO-605. Apr 19, 2021 185
Therapeutic Role of Phytochemicals in the Prevention of Oral Potentially Malignant Disorders and Oral Cancer--A Review. Nagi, Ravleen; Rakesh, N.; Reddy, Sujatha S.; Konidena, Aravinda; Makkad, Ramanpal Singh; Vyas, Taru Apr 19, 2021 5959
INOVIO's INO-4800 induced neutralizing antibodies and T cell responses against UK, South African and Brazilian COVID-19 variant strains. Apr 16, 2021 274
INOVIO's INO-4800 induced neutralizing antibodies and T cell responses against UK, South African and Brazilian COVID-19 variant strains. Apr 16, 2021 275
Inovio's COVID-19 vaccine candidate shows response against all tested variants. Apr 15, 2021 234
Tevogen Bio to announce encouraging preclinical data of TVGN-489 for COVID-19 at the 2021 Annual Meeting of American Association of Immunologists. Apr 13, 2021 174
Tevogen Bio to announce encouraging preclinical data of TVGN-489 for COVID-19 at the 2021 Annual Meeting of American Association of Immunologists. Apr 13, 2021 175
Achilles presents patient case study from ongoing Phase I/IIa THETIS trial. Apr 11, 2021 203
Harpoon Therapeutics announces data from poster presentations at AACR meeting. Apr 11, 2021 313
Hookipa announces preliminary Phase 1 immunogenicity data for HB-201, HB-202. Apr 11, 2021 515
Crispr Therapeutics presents preclinical data on CD70 Knockout. Apr 11, 2021 226
F-star Therapeutics shows differentiation of FS222 in 2021 AACR Poster. Apr 11, 2021 322
GOSH... JOSH IS A MIRACLE; Leukaemia boy's incredible recovery. EXCLUSIVE by Fiona Duffy Apr 11, 2021 477
SQZ presents preclinical data on mRNA-based eAPCs, potential applicability. Apr 11, 2021 374
Xencor presents data from preclinical XmAb Bispecific antibody/cytokine programs. Apr 11, 2021 671
NextCure presents preclinical data for NC762 at AACR Annual Meeting. Apr 11, 2021 153
ImmunityBio Says Single Prime hAd5 COVID-19 Vaccination Induces a 10-Fold Increase in T Cell Response Equivalent to T Cell Responses from Patients Previously Infected with SARS-CoV-2. Apr 9, 2021 818
ChemoCentryx announces poster presentation on CCX559. Apr 9, 2021 194
Sana Biotechnology presents preclinical data from T cell programs. Apr 9, 2021 297
ImmunityBio says single prime hAd5 COVID-19 vaccination induces T-cell responses. Clinical report Apr 8, 2021 285
Bioniz Therapeutics' BNZ-1 receives European Commission orphan designation. Apr 7, 2021 170
Bioniz Therapeutics' BNZ-1 receives European Commission orphan designation. Apr 7, 2021 171
CTL Mourns Odumakin, Says He Left A Huge Vacuum. Apr 4, 2021 323
Relapse of T-Cell Lymphoma as Isolated Brachial Plexus Neurolymphomatosis: A Case Report. Kibici, Kenan; Erok, Berrin; Atca, Ali Onder; Yegen, Gulcin Clinical report Apr 1, 2021 1679
The Retrospective Analysis of Patients Diagnosed with T-Cell Lymphoma at BezmialemVakif University's School of Medicine Hospital. Balci, Ece; Cetin, Guven Report Apr 1, 2021 357
UK-based Achilles Therapeutics unveils US$175.5mln IPO at Nasdaq debut. Apr 1, 2021 193
UK-based Achilles Therapeutics unveils US$175.5mln IPO at Nasdaq debut. Apr 1, 2021 193
Tiziana Life Sciences plans phase II trials of nasal antibody treatment in COVID-19 patients. Mar 31, 2021 241
Tiziana Life Sciences plans phase II trials of nasal antibody treatment in COVID-19 patients. Mar 31, 2021 241
New US study finds T cells induced by COVID-19 infection respond to COVID-19 virus variants. Report Mar 31, 2021 252
New US study finds T cells induced by COVID-19 infection respond to COVID-19 virus variants. Report Mar 31, 2021 251
ONE PFIZER DOSE 'BOOSTS IMMUNITY'. Mar 30, 2021 234
Equillium announces data from Equalise study in patients with SLE. Report Mar 30, 2021 173
Vaccine study's positive results; 99% SHOWING ROBUST RESPONSE FROM A DOSE. MIKE KELLY Reporter mike.kelly@ncjmedia.co.uk Mar 29, 2021 401
ImmunityBio Reports 12-Month Overall Survival Probability of 83% in NCI-Led Phase 1 Study of Multi-Targeted hAd5 Immunotherapy Vaccine in Patients with Advanced Metastatic Prostate Cancer. Mar 29, 2021 463
ImmunityBio announces results of multi-targeted Immunotherapy vaccine study. Mar 29, 2021 205
Avalon GloboCare, University of Pittsburgh enter collaboration. Mar 29, 2021 302
US Food and Drug Administration Approves Bristol Myers Squibb's and Bluebird Bio's Abecma for Relapsed or Refractory Multiple Myeloma. Mar 29, 2021 815
FDA approves Bristol Myers Squibb, Bluebird Bio's Abecma. Mar 28, 2021 263
Maxcyte: At the forefront of cell therapy revolution. Mar 25, 2021 503
Step Pharma Raises EUR 35m in series B Financing to Advance First in Class CTPS1 inhibitor into the Clinic in T Cell Malignancies. Mar 25, 2021 364
Sarah is first patient to trial new cancer treatment offering hope. LISA O'BRIEN lisa.obrien@mnamedia.co.uk Mar 25, 2021 465
Actinium Pharmaceuticals begins patient enrollment in Iomab-ACT trial. Mar 24, 2021 193
Mustang Bio reports FY20 EPS ($1.14), consensus ($1.01). Financial report Mar 24, 2021 186
ONK Therapeutics Licenses EBV-LCL Feeder Cell Line from NIH to Enhance NK Cell Expansion. Mar 22, 2021 565
ImmunityBio announces preclinical data on efficacy of PD-L1 t-haNK therapy. Mar 22, 2021 278
Chimeric Therapeutics has strong bank balance to progress ground-breaking CAR-T cell therapies for solid tumours. Mar 20, 2021 947
Chimeric Therapeutics doses first patient cohort for Phase 1 CLTX CAR T trial. Mar 19, 2021 347
T-Cure Bioscience Enters Agreement with Rutgers to Conduct Clinical Research of Novel T Cell Receptor Therapy for Treatment of Variety of Cancers. Mar 17, 2021 313
An open-label randomized clinical trial to evaluate the efficacy of everolimus versus tacrolimus in triple maintenance immunosuppressive therapy for kidney transplant patients. Assis, B.P.S.; Lasmar, M.F.; Fabreti-Oliveira, R.A.; Araujo, S.A.; Oliveira, J.; Wanderley, D.C.; Na Mar 17, 2021 5087
Tevogen Bio Forges Partnership with BioCentriq, New Jersey Innovation Institute's Cell and Gene Therapy Center, to Enhance Tevogen's Development Capacity of Its Proprietary Targeted T Cell Therapy For COVID-19. Mar 16, 2021 249
ImmunityBio Touts Positive Interim Phase I Safety Data of hAd5 T-Cell COVID-19 Vaccine Candidate in Oral and Sublingual Formulations. Mar 16, 2021 347
Scancell focuses on cancer immunotherapies and COVID-19 vaccine. Mar 16, 2021 498
Ewan wins battle in time for his 18th; young guitarist beat tumour on his spine to be an 'inspiration'. ROBERT SUTCLIFFE robert.sutcliffe@trinitymirror.com @MRRSUTCLIFFE Mar 9, 2021 483
ImmunityBio, NantKwest Begin Dosing Participants in Global Trials for Novel COVID-19 Vaccine. Mar 9, 2021 703
Gilead T-cell therapy gets US backing as third line cancer treatment. Mar 8, 2021 166
ISA Pharmaceuticals selects ISA106 COVID-19 immunotherapy for clinical trial. Mar 3, 2021 203
ISA Pharmaceuticals selects ISA106 COVID-19 immunotherapy for clinical trial. Mar 3, 2021 202
EVEREST SUPPORTS USA CLAY TARGET LEAGUE. Mar 1, 2021 286
T cells mount attacks against many SARS-CoV-2 targets. Mar 1, 2021 355
High Prevalence of Anemia among Human Immunodeficiency Virus-Infected Patients: A Cross-sectional Study in Bali-Indonesia. Aryastuti, Sri Agung; Dewi, SriRatna; Masyeni, Sri Report Mar 1, 2021 2969
Central Role of T Follicular Helper Cells in Myasthenia Gravis. Wu, Na; Tuzun, Erdem; Cheng, Yi; Yan, Li; Wu, Yajun; Huang, Hui; Li, Siyu; Shi, Ling; Wu, Xiaorong Mar 1, 2021 5365
Innate and Th1/Th17 adaptive immunity in acute and convalescent Brazilian borreliosis disease. Bonoldi, Virginia Lucia Nazario; Yoshinari, Natalino Hajime; de Aniz, Patricia Antonia Estima Abreu; Report Mar 1, 2021 5224
Effects of paternal lymphocyte immunization in women with unexplained infertility. Murni, Nani; Mansur, Indra Gusti; Rachman, Ichramsyah A.; Sadikin, Mohamad Report Feb 28, 2021 2061
Sub-genomic analysis of Chikungunya virus E2 mutations in Pakistani isolates potentially modulating B-cell and T-Cell immune response. Bilal Ahmed Khan, Saifullah, Amanullah Lail and Saeed Khan Feb 24, 2021 3015
Covid vaccines: We have been extremely lucky but may not be when the next pandemic strikes - Professor Eleanor Riley; Given the speed at which the global scientific community has developed at least six highly effective vaccines to combat a pandemic virus that was completely unknown barely a year ago, you might be forgiven for thinking that making vaccines is really easy. It isn't, or not always. Eleanor Riley Feb 22, 2021 618
First Patient Dosed in Phase 2 Study of NT-I7 and Opdivo. Report Feb 17, 2021 335
ImmunityBio partners with NantKwest to study hAd5 T-Cell COVID-19 Vaccine. Feb 12, 2021 285
ImmunityBio partners with NantKwest to study hAd5 T-Cell COVID-19 Vaccine. Feb 12, 2021 289
Tmunity Therapeutics Expands T Cell Engineered Therapy Collaboration. Feb 10, 2021 410
FDA Approves New Treatment for Adults with Relapsed or Refractory Large-B-Cell Lymphoma. Feb 8, 2021 618
US FDA approves Juno Therapeutics' Breyanzi to treat adults with relapsed or refractory large-B-Cell Lymphoma. Feb 8, 2021 187
US FDA approves Juno Therapeutics' Breyanzi to treat adults with relapsed or refractory large-B-Cell Lymphoma. Feb 8, 2021 183
Immune Checkpoint Inhibitor-Induced Upper Gastrointestinal Tract Inflammation Shows Morphologic Similarities to, but Is Immunologically Distinct From, Helicobacter pylori Gastritis and Celiac Disease. Irshaid, Lina; Robert, Marie E.; Zhang, Xuchen Report Feb 1, 2021 6049
Evaluation of Positive B- and T-Cell Gene Rearrangement Studies in Patients With Negative Morphology, Flow Cytometry, and Immunohistochemistry. Mendoza, Hadrian; Tormey, Christopher A.; Siddon, Alexa J. Report Feb 1, 2021 3106
BCMA CAR-T Therapy Cilta-cel Accepted for Accelerated Assessment in Europe for the Treatment of Relapsed and/or Refractory Multiple Myeloma. Feb 1, 2021 485
Teenager who beat cancer three times dies in parent's arms after catching Covid; Aspen Deke, 17, had struggled for most of her life with acute lymphoblastic leukemia, enduring both a a bone marrow transplant and CAR-T cell immunotherapy. By, William Walker Feb 1, 2021 397
MYCOSIS FUNGOIDES: Workup includes multiple biopsies. Jancin, Bruce Feb 1, 2021 1176
Tevogen Bio supports clinical trials of investigational curative T cell therapy for COVID-19 under HMP Partners funding. Jan 26, 2021 227
Tevogen Bio supports clinical trials of investigational curative T cell therapy for COVID-19 under HMP Partners funding. Jan 26, 2021 223
TScan Therapeutics Raises USD 100m in Series C Financing. Jan 26, 2021 327
TOP NEWS: Glaxo And Merck KGaA Discontinue Bintrafusp Alfa Trial. Jan 20, 2021 246
Faron Notes "Remarkable" Observations From Bexmarilimab Trial. Jan 20, 2021 327
Euroimmun Launches SARS-CoV-2 Test System to Detect T-Cell Response. Jan 14, 2021 245
KSQ Therapeutics and Takeda Forge Collaboration to Research, Develop and Commercialize Novel Immuno-Oncology Therapies. Jan 13, 2021 307
MaxCyte inks licensing deal with Myeloid Therapeutics to advance cancer therapies. Jan 12, 2021 310
Arix Bioscience portfolio firms Autolus and Imara issue updates. Jan 7, 2021 842
ImaginAb signs license and supply agreement for CD8 ImmunoPET Technology with Pfizer. Jan 7, 2021 197
ImaginAb signs license and supply agreement for CD8 ImmunoPET Technology with Pfizer. Jan 7, 2021 193
EpiVax, EpiVax Therapeutics Advance EPV-CoV-19 COVID-19 Vaccine Programme. Jan 4, 2021 357
EpiVax reveals details on progress of peptide-based COVID-19 vaccine. Jan 4, 2021 243
EpiVax reveals details on progress of peptide-based COVID-19 vaccine. Jan 4, 2021 239
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France. Gallais, Floriane; Velay, Aurelie; Nazon, Charlotte; Wendling, Marie-Josee; Partisani, Marialuisa; S Report Jan 1, 2021 5149
Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG. Schwarzkopf, Sina; Krawczyk, Adalbert; Knop, Dietmar; Klump, Hannes; Heinold, Andreas; Heinemann, Fa Report Jan 1, 2021 5801
Placental Morphology and Cellular Characteristics in Stillbirths in Women With Diabetes and Unexplained Stillbirths. Kerby, Alan; Shingleton, Daniel; Batra, Gauri; Sharps, Megan C.; Baker, Bernadette C.; Heazell, Alex Report Jan 1, 2021 5923
Achieving better outcomes for predictive analytics. Winkenbach, Matthias Jan 1, 2021 1343
DNA Methylation Patterns in [CD4.sup.+] T Cells of Naive and Influenza A Virus-Infected Mice Developmentally Exposed to an Aryl Hydrocarbon Receptor Ligand. Burke, Catherine G.; Myers, Jason R.; Post, Christina M.; Boule, Lisbeth A.; Lawrence, B. Paige Report Jan 1, 2021 16242
A case of statin-associated immune-mediated necrotizing myopathy with atypical biopsy features. Zaki, Mark M.; Virk, Zain M.; Lopez, Diego; Klubnick, Jenna; Ahrendsen, Jared T.; Varma, Hemant; Kyt Clinical report Jan 1, 2021 3317
ENDOTHELIAL PROTEIN C RECEPTOR EXPRESSION IS REGULATED BY SP1 TRANSCRIPTION FACTOR IN MURINE MICROGLIA. Tufekci, Kemal Ugur; Ates, Halil; Genc, Sermin Jan 1, 2021 4034
A clinical study of mucocutaneous manifestation of HIV/AIDs and its correlation with CD4 count. Niya Khat, Chandramohan Kudligi, Ravi Munasingh Rathod, Vidya Kuntoji, Pradeep Vittal Bhagwat, Sanja Clinical report Dec 31, 2020 3556
Frequency of undiagnosed HIV infection in patients of seborrheic dermatitis. Zaib, Khalida Ahtesham, Tahira Tabassum, Anam Ilyas, Sara Inayat, Zaeem Sohail Jafer and Ahmad Amin Dec 31, 2020 1724
Clinical and Laboratory Characteristics of Primary Immunodeficiency Patients from a Tertiary Care Center in Pakistan. Tipu, Hamid Nawaz; Ahmed, Dawood Report Dec 31, 2020 3709
Humanigen wins US patent for Lenzilumab in preventing cytokine storm and neurotoxicity related to CAR-T cell therapy. Dec 29, 2020 363
IMV Provides Update on COVID-19 Vaccine Program. Dec 28, 2020 586
Humanigen Secures US Patent for Lenzilumab in Preventing Cytokine Storm and Neurotoxicity Related to CAR-T Cell Therapy. Dec 28, 2020 375
Even mild Covid-19 cases may provide lasting immunity, shows study. Dec 25, 2020 511
Legend Biotech Initiates Rolling Submission of Biologics License Application to US FDA Seeking Approval of BCMA CAR-T Therapy Cilta-cel for the Treatment of Relapsed and/or Refractory Multiple Myeloma. Dec 22, 2020 659
Jessner's Lymphocytic Infiltrate--A Rare Case Report. Mishra, Preeti; Vagha, Sunita; Hiwale, Keshav; Shukla, Samarth Dec 21, 2020 1270
Janux Therapeutics partners with Merck to develop novel drug candidates for immuno oncology using TRACTr Technology. Dec 21, 2020 213
Janux Therapeutics partners with Merck to develop novel drug candidates for immuno oncology using TRACTr Technology. Dec 21, 2020 209
Janux Therapeutics Forges Collaboration with Merck to Develop Novel Drug Candidates for Immuno-Oncology Using T Cell Engager (TRACTr) Technology. Dec 21, 2020 372
Scancell Holdings chooses candidate for coronavirus vaccine. Dec 19, 2020 346
There's more to Covid immunity than antibodies; 2 MINUTES ON... DR MIRIAM STOPPARD Dec 18, 2020 153
There's more to Covid immunity than antibodies; DMUULS 42 DAILY MIRROR FRIDAY 18.12.2020 Dr Miriam Stoppard MINUTES ON... Dr Miriam Stoppard Dec 18, 2020 153
Scancell Shares Rise As It Chooses Vaccine Candidate For Development. Dec 18, 2020 207
A RAPID RESPONSE VACCINE DEVELOPMENT STRATEGY FOR NEWCASTLE DISEASE IN POULTRY. Maremagae, S.R.; Bezuidenhout, C.C.; Murphy, A.M.; Jarvis, M.A.; Naicker, P.; Lebea, P.J. Report Dec 15, 2020 4741
ImmunityBio's hAd5 T-Cell COVID-19 Vaccine Candidate Shows Complete Protection of Airways in Non-Human Primates. Dec 10, 2020 744
Newspaper executive from Grayslake championed industry's causes Kramer: Memorial service will be held in Gurnee. Christopher Placek cplacek@dailyherald.com Dec 9, 2020 523
Bayer & Atara Biotherapeutics partnership leverage mesothelin-targeted CAR T-cell therapies for solid tumors. Dec 7, 2020 296
Bayer & Atara Biotherapeutics partnership leverage mesothelin-targeted CAR T-cell therapies for solid tumors. Dec 7, 2020 300
Bayer, Atara Biotherapeutics Team To Develop Solid Tumour Therapies. Dec 7, 2020 265
Preclinical Data Demonstrate Anti-Viral Activity of AlloVir's ALVR109, an Allogeneic, Off-the-Shelf SARS-CoV-2 Specific T Cell Therapy. Dec 7, 2020 443
Role of Th2 type Cytokines and IgE in Asthmatic Children. Abo-Shanab, Assem Metwally; Elnady, Hala; Helwa, Iman; Abdelkawy, Rania Fawzy Mahmoud; Atta, Hanan; Report Dec 1, 2020 4466
Role Of T Cells In MS. Dec 1, 2020 281
Boosting Stem Cell Activity Can Enhance Immunotherapy Benefits. Nov 30, 2020 155
Cancer Patient Treated With Stem Cell Transplant Later Develops Retinal Condition. Nov 16, 2020 446
Maxcyte: At the forefront of cell therapy revolution. Nov 14, 2020 729
TScan Therapeutics Forges Partnership with Qiagen to Develop T Cell-Based Laboratory Test for Comprehensive COVID-19 Immune Response. Nov 11, 2020 423
Vor Biopharma Gains Exclusive License of Clinical-Stage CD33 CAR-T from National Cancer Institute. Nov 11, 2020 403
Oxford Biomedica clinches CAR-T cell therapies collaboration with PhoreMost. Nov 10, 2020 246
ImmunityBio's hAd5 COVID-19 Vaccine Candidate Stimulates Memory T-Cell Recall in Patients Infected with SARS-CoV-2. Nov 9, 2020 525
ImmunityBio declares positive study results for human Ad5 (hAd5) COVID-19 vaccine candidate. Nov 9, 2020 240
ImmunityBio declares positive study results for human Ad5 (hAd5) COVID-19 vaccine candidate. Nov 9, 2020 236
Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development. Nov 9, 2020 185
Immunity stronger in those who had symptoms. Nov 5, 2020 281
Humanigen to present abstract covering a lymphoma study of its drug lenzilumab at hematology conference. Conference news Nov 5, 2020 303
NA Proactive news snapshot: Humanigen, Metalla Royalty & Streaming, DGTL Holdings, Tetra Bio-Pharma UPDATE ... Nov 5, 2020 2204
First Patient Dosed with Camidanlumab Tesirine in Combination with Pembrolizumab in Ongoing Phase 1b Clinical Trial in Selected Solid Tumors. Nov 4, 2020 614
University study reveals six-month 'cellular immunity' from Covid-19. Nov 3, 2020 213
T-cell study adds to debate over duration of Covid-19 immunity. Reuters News Service Nov 2, 2020 416
Study Using Stem Cell-Based Crohn's Treatment Begins At Cleveland Clinic. Clinical report Nov 2, 2020 261
Cold autoimmune haemolytic anaemia as the presenting feature in a patient with angioimmunoblastic T-cell lymphoma an illustrative case. Gates, Shirley May; Lombard, Elizabeth Nov 1, 2020 2627
Unveiling the Immunomodulatory Characteristics of Haemonchus contortus Ephrin Domain Containing Protein in the Parasite-Host Interactions. Aimulajiang, Kalibixiati; Wen, Zhaohai; Tian, Xiaowei; Lakho, Shakeel Ahmed; Zhang, Yang; Naqvi, Muh Nov 1, 2020 6891
PeproMene Bio submits US FDA Investigational New Drug application to study PMB-101. Oct 29, 2020 214
PeproMene Bio submits US FDA Investigational New Drug application to study PMB-101. Oct 29, 2020 210
Immatics presents preclinical PoC data for IMA401. Oct 29, 2020 316
Bellicum Pharmaceuticals says BPX-601 trial did not observe clinical efficacy. Oct 29, 2020 186
Rubius Therapeutics presents new preclinical RTX-321 data at FOCIS meeting. Oct 28, 2020 333
Compugen to present data on potential of PVRIG in cancer inmunotherapy. Oct 27, 2020 175
Daiichi Sankyo doses first patient in cancer drug DS-1055 study. Oct 23, 2020 194
Daiichi Sankyo doses first patient in cancer drug DS-1055 study. Oct 23, 2020 198
CureVac announces data from preclinical SARS-CoV-2 vaccine candidate studies. Oct 23, 2020 427
UK's Vaccine Taskforce partners with Oxford Immunotech to assess COVID-19 vaccine T cell responses. Oct 22, 2020 186
UK's Vaccine Taskforce partners with Oxford Immunotech to assess COVID-19 vaccine T cell responses. Oct 22, 2020 190
Soligenix's SGX301 shows improved response in Phase 3 T-cell lymphoma study. Oct 22, 2020 174
Actinium Pharmaceuticals awarded grant by NIH to study Iomab-ACT. Oct 21, 2020 177
Crispr Therapeutics reports top-line results from Phase 1 CARBON trial of CTX110. Oct 21, 2020 527
First Patient Dosed in Phase 1 Clinical Trial of Second-Generation COVID-19 Vaccine Candidate Delivering Both Spike and Nucleocapsid of SARS-CoV-2. Oct 21, 2020 1017
European CHMP Adopts Positive Opinion for Kite's KTE-X19 for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma. Oct 20, 2020 523
Boehringer Ingelheim, Oxford BioTherapeutics Expand Collaboration to Discover Novel Selective Tumor Targets as First Bispecific Antibody Advanced into the Clinic. Oct 19, 2020 333
Minor Changes In Immune Cells Have Major Effect On Immune Response. Oct 19, 2020 686
FDA Authorizes Phase 1 Trial of ImmunityBio's Novel COVID-19 Vaccine Candidate hAd5. Oct 16, 2020 483
OncoPep Strengthens Pipeline with Addition of Multi-Tumor Antigen Adoptive T Cell Therapy. Oct 15, 2020 356
Tevogen Bio submits clinical trials of T Cell IND with FDA to develop treatment for COVID-19. Oct 15, 2020 189
Tevogen Bio Submits IND Submitted to FDA for Clinical Trials of T Cell Treatment for COVID-19. Oct 15, 2020 355
Tevogen Bio submits Investigational New Drug application for COVID-19 treatment development. Oct 15, 2020 167
Tevogen Bio submits clinical trials of T Cell IND with FDA to develop treatment for COVID-19. Oct 15, 2020 193
Tevogen Bio submits Investigational New Drug application for COVID-19 treatment development. Oct 15, 2020 171
NantKwest affiliate ImmunityBio gets FDA approval for hAd5-COVID-19 trial. Oct 15, 2020 188
Precision BioSciences says U.S. PTAB upholds allogeneic CAR T patents. Oct 15, 2020 271
MacroGenics announces publication of flotetuzumab data. Oct 15, 2020 262
Scancell focuses on cancer immunotherapies and COVID-19 vaccine. Oct 13, 2020 529
Twist Bioscience, Neogene announce strategic partnership for T cell therapies. Oct 13, 2020 216
Axis Therapeutics, a n Athenex and XLifeSc JV, in pact with h PharmaEssentia. Oct 12, 2020 217
Vir Biotechnology announces publication of research on monoclonal antibodies. Oct 9, 2020 274
NEC OncoImmunity AS, Oslo University Hospital Team Up to Develop a Diagnostic for COVID-19 Using Artificial Intelligence. Oct 9, 2020 499
ChromaDex's licensed nicotinamide riboside shows anti-cancer function in study. Oct 8, 2020 183
Antibodies fight off the new coronavirus, but what do T cells do? Oct 7, 2020 371
Heat Biologics issued new patent for gp96 platform with ICOSL. Oct 7, 2020 232
A2 Biotherapeutics Closes USD 71.5m Series B Financing. Oct 7, 2020 344
BioNTech, Pfizer initiate rolling submission to EMA for BNT162b2. Oct 6, 2020 191
Corvus Pharmaceuticals announces updated data from Phase 1 study of CPI-006. Oct 5, 2020 896
Miragen says cobomarsen lacks a 'compelling result' for primary endpoint. Oct 5, 2020 236
Christie patient takes on virtual London marathon. Oct 2, 2020 212
Avalon expands AVA-001 trial to non-Hodgkin lymphoma patients; plans acute respiratory distress syndrome trial for later this year. Oct 2, 2020 436
Mustang Bio doses first patient in Phase 1/2 trial of MB-102. Oct 1, 2020 201
Avalon GloboCare provides clinical updates on CAR, MSC programs. Oct 1, 2020 443
Determination of B- and T- cell epitopes for Helicobacter pylori cagPAl: An in silico approach. Tas, Sevgi Kalkanli; Kirkik, Duygu; Ozturk, Kubra; Tanoglu, Alpaslan Report Oct 1, 2020 4027
Leucocytes and Th-associated Cytokine Profile of HIV-Leishmaniasis Co-Infected Persons Attending Abuja Teaching Hospital, Nigeria. Abdullahi, Idris Nasir; Emeribe, Anthony Uchenna; Adekola, Hafeez Aderinsayo; Muhammad, Habiba Yahay Oct 1, 2020 5069
Caerin 1 Antimicrobial Peptides that Inhibit HIV and Neisseria May Spare Protective Lactobacilli. Rollins-Smith, Louise A.; Smith, Patricia B.; Ledeczi, Anna M.; Rowe, Julia M.; Reinert, Laura K. Report Oct 1, 2020 5560
Determination of B- and T-cell epitopes for Helicobacter pylori cagPAI: An in silico approach. Tas, Sevgi Kalkanli; Kirkik, Duygu; Ozturk, Kubra; Tanoglu, Alpaslan Oct 1, 2020 4247
Maternal Supplementation with Dietary Betaine during Gestation to Improve Twin Lamb Survival. Brougham, Billie-Jaye; Weaver, Alice C.; Swinbourne, Alyce M.F.; Baida, Bobbie E. Lewis; Kelly, Jenn Report Oct 1, 2020 8942
HUYA Bioscience receives Japanese orphan drug designation for HBI-8000. Sep 29, 2020 163
HUYA Bioscience receives Japanese orphan drug designation for HBI-8000. Sep 29, 2020 159

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |